A randomized phase 3 study of 527 women with menopausal hot flashes suggests that fezolinetant can significantly reduce the intensity of the symptoms. This makes this neurokinin-3 receptor (NK3R) antagonist possibly a good option for women for whom hormone replacement treatment is not desirable, researchers say. The Lancet.
Annoying symptoms associated with…
The entire content of this article is only accessible to subscribers.
Read 3 articles FREE
Make an account. Free and without obligation.
I want 3x free
Always access to all NTvG publications?
Subscribe today!
Take the introductory subscription
€ 32.95 for 12 weeks!
I want to meet
Do you already have a subscription? login
